Laboratory Medicine Quality Indicators A Review of the Literature

被引:95
作者
Shahangian, Shahram [1 ]
Snyder, Susan R.
机构
[1] Ctr Dis Control & Prevent, Lab Practice Evaluat, Div Lab Syst, Natl Ctr Preparedness Detect & Control Infect Dis, Atlanta, GA USA
关键词
Laboratory medicine; Quality indicator; Quality measure; Laboratory test utilization; Laboratory service delivery; Health outcome; PATHOLOGISTS Q-PROBES; TEST TURNAROUND TIME; BLOOD CULTURE CONTAMINATION; SPECIMEN IDENTIFICATION ERRORS; ROUTINE INDIVIDUAL FEEDBACK; TEST-ORDERING BEHAVIOR; RANDOMIZED-TRIAL; FOLLOW-UP; EMERGENCY-DEPARTMENT; CRITICAL-VALUES;
D O I
10.1309/AJCPJF8JI4ZLDQUE
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We summarize information on quality indicators related to laboratory testing from published literature and Inlet-net sources to assess current gaps with respect to stages of the laboratory testing process, the Institute of Medicine (IOM) health care domains, and quality measure evaluation criteria. Our search strategy used various general and specific terms for clinical conditions and laboratory procedures. References related to a potential quality indicator associated with laboratory testing and an IOM health care domain were included. With the exception of disease- and condition-related indicators originating from clinical guidelines, the laboratory medicine quality indicators reviewed did not satisfy minimum standard evaluation criteria for quality or performance measures (ie, importance, scientific acceptability, and feasibility) and demonstrated a need across the total laboratory testing process for consistently; specified, useful, and evidence-based, laboratory-related quality and performance measures that are important to health outcomes and meaningful to health care stakeholders for which laboratories can be held accountable.
引用
收藏
页码:418 / 431
页数:14
相关论文
共 135 条
[71]   Quality improvement report - Linking guideline to regular feedback to increase appropriate requests for clinical tests: blood gas analysis in intensive care [J].
Merlani, P ;
Garnerin, P ;
Diby, M ;
Ferring, M ;
Ricou, B .
BRITISH MEDICAL JOURNAL, 2001, 323 (7313) :620-624
[72]   National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes [J].
Morrow, David A. ;
Cannon, Christopher P. ;
Jesse, Robert L. ;
Newby, L. Kristin ;
Ravkilde, Jan ;
Storrow, Alan B. ;
Wu, Alan H. B. ;
Christenson, Robert H. ;
Apple, Fred S. ;
Francis, Gary ;
Tang, Wilson .
CLINICAL CHEMISTRY, 2007, 53 (04) :552-574
[73]  
Nakhleh RE, 1996, ARCH PATHOL LAB MED, V120, P227
[74]  
Nakhleh RE, 1998, ARCH PATHOL LAB MED, V122, P303
[75]  
*NAT COMM QUAL ASS, MEAS QUAL IMPR HLTH
[76]   The impact of peer management on test-ordering behavior [J].
Neilson, EG ;
Johnson, KB ;
Rosenbloom, ST ;
Dupont, WD ;
Talbert, D ;
Giuse, DA ;
Kaiser, A ;
Miller, RA .
ANNALS OF INTERNAL MEDICINE, 2004, 141 (03) :196-204
[77]   Contamination rates of blood cultures obtained by dedicated phlebotomy vs intravenous catheter [J].
Norberg, A ;
Christopher, NC ;
Ramundo, ML ;
Bower, JR ;
Berman, SA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (06) :726-729
[78]  
Novak RW, 2002, ARCH PATHOL LAB MED, V126, P147
[79]  
Novis DA, 2004, ARCH PATHOL LAB MED, V128, P621
[80]  
Novis DA, 2004, ARCH PATHOL LAB MED, V128, P158